Cocrystal Pharma, Inc.

Nasdaq:COCP

Pharmaceutical Preparations·BOTHELL, WA

" Several subclassifications of cocrystals exist.

CEO

Lee Sam

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
10-Q	Q2 2024	6/30/24	8/14/24	→
↓

Earnings Releases (8-K)

15 shown

Filed	Period
11/14/25	Q4 FY2025	→
8/14/25	Q3 FY2025	→
5/15/25	Q2 FY2025	→
3/31/25	Q1 FY2025	→
11/13/24	Q4 FY2024	→
8/14/24	Q3 FY2024	→
↓

News (8-K)

65 shown

Filed	Type	Description
3/13/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
3/9/26	Reg FD	Regulation FD Disclosure	→
2/19/26	Reg FD	Regulation FD Disclosure	→
1/15/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/18/25	Reg FD	Regulation FD Disclosure	→
12/1/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
9/29/25	424B3	424B3	→
9/19/25	S-1	S-1	→
9/15/25	424B5	424B5	→
9/12/25	424B3	424B3	→
6/15/23	424B5	424B5	→
5/24/23	S-3/A	S-3/A	→
↓

Filing History(645 filings)

TypeDateAccessionPeriodSize

8-K

Mar 13, 2026

0001493152-26-0100718-K

Mar 10, 2026

192.6 KB

8-K

Mar 9, 2026

0001493152-26-0093098-K

Mar 9, 2026

251.1 KB

Feb 25, 2026

0001493152-26-0080394

Feb 24, 2026

7.4 KB

8-K

Feb 19, 2026

0001493152-26-0074308-K

Feb 19, 2026

243.6 KB

Feb 9, 2026

0001493152-26-0057734

Feb 6, 2026

7.4 KB

8-K

Jan 15, 2026

0001493152-26-0024228-K

Jan 9, 2026

209.8 KB

Jan 13, 2026

0001683168-26-000263

Jan 9, 2026

6.0 KB

Jan 13, 2026

0001493152-26-0020424

Jan 9, 2026

6.1 KB

Jan 13, 2026

0001493152-26-0020384

Jan 9, 2026

6.1 KB

Jan 13, 2026

0001493152-26-0020374

Jan 9, 2026

6.2 KB

Jan 13, 2026

0001493152-26-0020364

Jan 9, 2026

6.1 KB

Jan 13, 2026

0001493152-26-0020354

Jan 9, 2026

6.7 KB

Jan 13, 2026

0001493152-26-0020344

Jan 9, 2026

6.1 KB

Jan 13, 2026

0001493152-26-0020334

Jan 9, 2026

6.1 KB

Jan 2, 2026

0001493152-26-000114

Dec 31, 2025

7.4 KB

Dec 31, 2025

0001493152-25-0297964

Dec 30, 2025

7.4 KB

Dec 29, 2025

0001493152-25-0292574

Dec 24, 2025

9.3 KB

8-K

Dec 18, 2025

0001493152-25-0282968-K

Dec 18, 2025

247.8 KB

8-K

Dec 1, 2025

0001493152-25-0255688-K

Dec 1, 2025

227.9 KB

Nov 28, 2025

0001493152-25-025314

Nov 26, 2025

8.5 KB

Nov 25, 2025

0001493152-25-025048

Nov 25, 2025

7.4 KB

8-K

Nov 14, 2025

0001493152-25-0226038-K

Nov 14, 2025

306.3 KB

10-Q

Nov 14, 2025

0001493152-25-02258110-Q

Sep 30, 2025

4.3 MB

SCHEDULE 13D/A

Oct 30, 2025

0001493152-25-020250

—

14.0 KB

Oct 30, 2025

0001493152-25-0202224

Oct 28, 2025

9.8 KB

25 filings shown

Filed	Form	Description
5/5/25	DEFA14A	DEFA14A	→
5/5/25	DEF 14A	DEF 14A	→
4/25/25	PRE 14A	PRE 14A	→
5/7/24	DEF 14A	DEF 14A	→
4/26/24	PRE 14A	PRE 14A	→
4/28/23	DEF 14A	DEF 14A	→
↓

Cocrystal Pharma, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(645 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/25/26	4	4	→
2/9/26	4	4	→
1/13/26	4	4	→
1/13/26	4	4	→
1/13/26	4	4	→
1/13/26	4	4	→
↓

Filed	Form	Description
10/30/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
10/2/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
9/25/25	EFFECT	EFFECT	→
5/26/23	EFFECT	EFFECT	→
5/13/20	EFFECT	EFFECT	→
5/22/19	EFFECT	EFFECT	→
↓